|
|
List of sponsors 
If you are interested in sponsorship opportunities at this event then please contact:
Ince Saleem, Sponsorship manager
Email: ince.saleem@terrapinn.com
Tel: +44 (0) 20 7539 4323
Fax: +44 (0) 7984 479 740
|
Silver sponsor
|
Stem Cell Pharma Inc. (SCPI) is a privately held bio-pharmaceutical company founded in May of 2005, with a capitalization of 10 mm shares, out of which 3.3mm are issued and outstanding.
SCPI owns the world wide rights to an Invention “An Amniotic Membrane Stem Cell Telomerase Enhanced Implant, Manufacturing And Clinical Uses” by Alfred T. Sapse MD (r) its President and Founder. This invention is a novel approach to harvest embryonic stem cells from the amniotic membrane, a translucid sheet covering placenta. These embryonic cells can potentially repair and if needed rebuild practically all organs, tissues and cells, through a process of differentiation, once introduced in the human body.
The implant had been used with impressive results in the treatment of neuro degenerative diseases such a Multiple Sclerosis (MS), ALS (Lou Gehrig’s Disease), Parkinson’s, in eye diseases (Retinitis Pigmentosa - RP, Usher’s Syndrome – RP plus deafness), Muscular Dystrophy (MDA) including Duchenne’s, children diseases such as Cerebral Dystrophy and Epilepsy, autoimmune (Lupus Erythematosus (LE), and especially in the treatment of symptoms of aging. Clinical studies commenced in the US are now being carried out abroad and some of the results obtained might be used in the United States in the future IND’s submissions to the FDA.
|
|
|
|
|
